Switching to Doravirine/Lamivudine/Tenofovir Disoproxil...

JAIDS Journal of Acquired Immune Deficiency Syndromes 2019 / 08 Vol. 81; Iss. 4

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks

Johnson, Margaret, Kumar, Princy, Molina, Jean-Michel, Rizzardini, Giuliano, Cahn, Pedro, Bickel, Markus, Mallolas, Josep, Zhou, Yan, Morais, Cristiana, Kumar, Sushma, Sklar, Peter, Hanna, George J.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
81
Journal:
JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI:
10.1097/qai.0000000000002056
Date:
August, 2019
File:
PDF, 831 KB
2019
Conversion to is in progress
Conversion to is failed